Invesco Biotechnology & Genome ETF (PBE) Expected Move

Tracking the PBE expected move helps you see how far Invesco Biotechnology & Genome ETF's options market is pricing the stock to travel over a given period — whether that's the next day, week, or earnings cycle. Invesco Biotechnology & Genome ETF's expected move is derived directly from option premiums and gives you an objective range to plan trades, set strikes, and manage risk. Use our scanner to monitor the PBE expected move for this week's options, in real time.

The expected move is typically calculated from at-the-money straddle prices (or a blend of straddles and strangles) and represents roughly a one-standard-deviation range over the chosen timeframe. For PBE, comparing the implied expected move to actual realized moves over similar windows tells you whether the options market has historically overestimated or underestimated volatility. The PBE expected move for this week's options pricing is especially useful for short-dated traders, earnings players, and anyone selling premium who needs to know where the market thinks Invesco Biotechnology & Genome ETF is unlikely to go.

The Invesco Biotechnology & Genome ETF (Fund) is based on the Dynamic Biotech & Genome Intellidex Index (Index). The Fund will normally invest at least 90% of its total assets in the securities that comprise the Index. The Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Index is comprised of securities of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances in biotechnology and genetic engineering and research.

The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.

Iron condors, weekly premium sales, directional swing trades — they all live or die by where the market thinks the stock won't go. Our scanner tracks the PBE expected move across every expiration, benchmarks it against realized moves, and shows you when implied ranges are out of line with history. The Invesco Biotechnology & Genome ETF expected move for this week's options is the fastest read on short-term risk, which gives you a quick way to interpret what the options market thinks about PBE.